Using a Remote Patient Monitoring Alert System to Improve Care
NCT02933840 is an interventional trial sponsored by Massachusetts General Hospital. As of 18 Nov 2026, it was withdrawn. It studies Cardiovascular Abnormalities, Fractures, Bone and 2 more conditions. The registry lists an enrollment of 0 participants. The registry lists a start date of 31 Jan 2017 and a primary completion date of 31 Jan 2017.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02933840 |
| Status | Withdrawn |
| Study type | Interventional trial |
| Lead sponsor | Massachusetts General Hospital |
| Enrollment | 0 |
| Conditions | Cardiovascular Abnormalities, Fractures, Bone, Hemorrhage and Respiratory System Abnormalities |
| Start | 31 Jan 2017 |
| Primary completion | 31 Jan 2017 |
| Study completion | 31 Jan 2017 |
| Last update posted | 31 Oct 2019 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Aalok V Agarwala, MD, MBA
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02933840
Each answer restates registry values shown on this page.
What is NCT02933840?
NCT02933840 is an interventional trial sponsored by Massachusetts General Hospital. It studies Cardiovascular Abnormalities, Fractures, Bone and 2 more conditions.
Who leads NCT02933840?
The registry names Aalok V Agarwala, MD, MBA (principal investigator, Massachusetts General Hospital) as the overall official.
When did NCT02933840 end?
The registry lists a primary completion date of 31 Jan 2017 and a study completion date of 31 Jan 2017. The sponsor last updated the record on 31 Oct 2019.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.